Finzati - Logo
VCYT logo

Veracyte, Inc.

VCYT • Medical - Diagnostics & Research
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$4.77B
Growth
29.0%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 12.8%Positive revenue growth · 19.4%Positive free cash flow · 1.61Manageable debt level · 0.03Healthy liquidity · 8.15
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$4.77B
52W Range22.92 - 60.91
Beta1.93
Gross Margin69.62%
Oper. Margin14.34%
Profit Margin12.83%
Debt/Eq0.03
Current Ratio8.15
Quick Ratio7.81
Revenue 5Y28.99%

Investment DNA

How strong this company looks for long-term investors

74
out of 100
Business Quality
Margins, moat, returns
75/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
47/100
Why this score▼
Stable or improving margins · 12.8%Positive revenue growth · 19.4%Positive free cash flow · 1.61Manageable debt level · 0.03Healthy liquidity · 8.15Expensive earnings multiple · 49.86

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$47.00
Mean
$59.83
Median
$62.50
High
$69.00

Company Overview

IPO: 10/29/2013
Industry: Medical - Diagnostics & Research
P/B i: 2.53
Debt / Equity i: 0.03
Operating Margin: 14.34%
Net Margin: 12.83%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 8.15
Quick Ratio: 7.81
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
EASTHAM KARIN
Transaction: 06/18/2026
SELL
Change
-529
Price
$53.55
Filing
06/22/2026
Type
SELL
Miller Thomas F.
Transaction: 06/11/2026
BUY
Change
+5,272
Price
Not reported
Filing
06/15/2026
Type
BUY
Bhanji Muna
Transaction: 06/11/2026
BUY
Change
+5,272
Price
Not reported
Filing
06/15/2026
Type
BUY